Your browser doesn't support javascript.
loading
EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients.
Wei, Sheng; Shao, Jingjing; Wang, Jinming; Zhao, Tianye; Liu, Jia; Shen, Xiying; Wang, Yidan; Chen, Haizhen; Wang, Gaoren.
Afiliação
  • Wei S; Department of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Shao J; Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Wang J; Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Zhao T; Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Liu J; Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Shen X; Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Wang Y; Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Chen H; Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
  • Wang G; Department of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
J Thorac Dis ; 14(7): 2652-2664, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35928621

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article